parkinson’s disease

FDA-mandated clinical holds, strategic partnership breakups and $800 million biotech acquisitions. In this episode of the Xtalks Life Science Podcast, Sarah revisits two Parkinson’s biotech companies — Prevail Therapeutics and Voyager Therapeutics — to see what progress they’ve made in their gene therapy clinical development programs since April 2019. She shares how well the firms have weathered the COVID-19 pandemic, and the team discusses the outlook for the drug development industry in general.

Also in this episode, Ayesha explores the link between Parkinson’s disease and melanoma, and how gene therapies could target both. The team discusses the disconnect between basic, academic research and applied research in industry, and how funding is at the heart of the problem.

Read the full articles here:

6 Parkinson’s Biotech Companies: Where Are They in 2021?

Parkinson’s and Melanoma Share an Amyloid Link, Says New Research

For more life science and medical device content, visit the Xtalks Vitals homepage.

Follow Us on Social Media

Twitter: @Xtalks
Instagram: @Xtalks
Facebook: https://www.facebook.com/Xtalks.Webinars/
LinkedIn: https://www.linkedin.com/company/xtalks-webconferences
YouTube: https://www.youtube.com/c/XtalksWebinars/featured

Science writer and reporter Erik Vance says today’s brain scientists are like astronomers of old: They’ve unsettled humanity’s sense of itself by redrawing our picture of the cosmos within our own heads. Vance has investigated the healing power of stories and the “theater of medicine” (white coats included). It turns out that the things that make us feel better are often more closely connected to what we believe and fear than to the efficacy of some treatments. In fact, most drugs that go to trial can’t beat what we’ve dismissively called the “placebo effect,” which is actually nothing less than an unleashing of the brain’s superpowers.

Erik Vance is a Pulitzer Center grantee and the author of “Suggestible You: The Curious Science of Your Brain's Ability to Deceive, Transform, and Heal.” His work has appeared in several publications, including the “New York Times,” “Harper’s Magazine,” “Scientific American,” and “National Geographic.“

Find the transcript for this show at onbeing.org.

Science writer and reporter Erik Vance says today’s brain scientists are like astronomers of old: They’ve unsettled humanity’s sense of itself by redrawing our picture of the cosmos within our own heads. Vance has investigated the healing power of stories and the “theater of medicine” (white coats included). It turns out that the things that make us feel better are often more closely connected to what we believe and fear than to the efficacy of some treatments. In fact, most drugs that go to trial can’t beat what we’ve dismissively called the “placebo effect,” which is actually nothing less than an unleashing of the brain’s superpowers.

Erik Vance is a Pulitzer Center grantee and the author of “Suggestible You: The Curious Science of Your Brain's Ability to Deceive, Transform, and Heal.” His work has appeared in several publications, including the “New York Times,” “Harper’s Magazine,” “Scientific American,” and “National Geographic.“ 

This interview is edited and produced with music and other features in the 

On Being

 episode "Erik Vance — The Drugs Inside Your Head." Find more at onbeing.org.